<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:g="http://base.google.com/ns/1.0" xmlns:c="http://base.google.com/cns/1.0">
    <channel>
        <title><![CDATA[Antiviral]]></title>
        <description><![CDATA[Descriptions and reviews of books, products and treatments relating to environmental illnesses.]]></description>
        <link>http://www.ei-resource.org/</link>
                                        <item>
                                <guid>http://www.ei-resource.org/treatment-%11-medications/antiviral/ampligen-(hemispherx)/</guid>
                <title><![CDATA[Ampligen (Hemispherx)]]></title>
                <link>http://www.ei-resource.org/treatment-%11-medications/antiviral/ampligen-(hemispherx)/</link>                
                <description><![CDATA[
                                

	&nbsp;



	Ampligen (AMPLIfied GENetic activity) is an antiviral and immunomodulatory drug developed by Hemispherx in the late 1980s. Its primary proposed use is in the treatment of chronic fatigue syndrome (ME/CFS)....                ]]></description>
                <category><![CDATA[Antiviral]]></category>
                <pubDate>Tue, 07 Oct 2008 17:37:21 +0100</pubDate>
                <g:id>2342</g:id>
                <g:publish_date>2008-10-07</g:publish_date>
                                                                                    
            </item>
                        </channel>
</rss>
